Counterpoint Mutual Funds’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Counterpoint Mutual Funds's DGX Position: Q3 2026 in Review
Counterpoint Mutual Funds opened a new position in Quest Diagnostics (DGX) in Q3 2026: 3,086 shares worth $719K. The stake represents 0.06% of the portfolio and ranks #104 among its holdings.
1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Counterpoint Mutual Funds held 3,086 shares of Quest Diagnostics worth $719K as of Q3 2026.
- Quest Diagnostics was a new Counterpoint Mutual Funds position in Q3 2026.
- Quest Diagnostics made up 0.06% of Counterpoint Mutual Funds's portfolio in Q3 2026, its #104 holding.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.